Instil Bio Inc TIL

Healthcare Biotechnology

Instil Bio, Inc. is a clinical-stage biopharmaceutical company focused on developing a pipeline of novel therapies. The Company seeks to in-license/acquire and develop novel therapeutic candidates in diseases with significant unmet medical need. Its first such program is an engineered tumor infiltrating lymphocyte (TIL), cell therapy for the treatment of cancer. It is engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor (CoStAR), platform. The Company's lead CoStAR-TIL product candidate, ITIL-306, expresses a CoStAR molecule designed to recognize folate receptor alpha (Fra), a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC and renal cancer. CAR-T and TCR-T therapies are cell products composed of T cells that have been genetically engineered to recognize a specific cancer-related antigen on the surface of tumor cells.

NDAQ:TIL - Post by User

Instil Bio Inc

Bullboard Posts

Comment by thegoldfishon Mar 25, 2014 1:45pm

124 Views

Post# 22365332

RE:SP of AMB

Scorpio, you wrote: "If SP goes back to .07 cents it may go down further."
------

Wow, great insight. Might want to add these to your analysis arsenal:

If it rains tomorrow, we may get wet.

The longer a strike goes, the less chance there is of an early settlement.

No matter how high the eagle flies, you can still break a windshield with a hammer.

You can't tell which way the train went by the tracks.

Bullboard Posts

Three micro-cap value stocks trading at peak pessimism